0001209191-19-039017.txt : 20190625
0001209191-19-039017.hdr.sgml : 20190625
20190625185832
ACCESSION NUMBER: 0001209191-19-039017
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190625
FILED AS OF DATE: 20190625
DATE AS OF CHANGE: 20190625
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EDWARDS MARK G
CENTRAL INDEX KEY: 0001190429
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35068
FILM NUMBER: 19919655
MAIL ADDRESS:
STREET 1: ALLOS THERAPEUTICS, INC.
STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001427925
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: 650-216-3500
MAIL ADDRESS:
STREET 1: 351 GALVESTON DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-06-25
0
0001427925
ACELRX PHARMACEUTICALS INC
ACRX
0001190429
EDWARDS MARK G
C/O ACELRX PHARMACEUTICALS, INC.
351 GALVESTON DRIVE
REDWOOD CITY
CA
94063
1
0
0
0
Common Stock
2019-06-25
4
A
0
3750
0.00
A
203750
D
Stock Option (Right to Buy)
2.19
2019-06-25
4
A
0
7500
0.00
A
2019-07-25
2029-06-25
Common Stock
7500
7500
D
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
The restricted stock units shall vest in two equal consecutive annual installments on June 25, 2020 and June 25, 2021, subject to Reporting Person's continuous service to the Company.
The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Reporting Person's continuous service to the Company.
/s/ Martha Adler, Attorney-In-Fact
2019-06-25